Targeted Next-Generation Sequencing of Endometrial Cancer and Matched Circulating Tumor DNA: Identification of Plasma-Based, Tumor-Associated Mutations in Early Stage Patients

There is currently no blood-based marker in routine use for endometrial cancer patients. Such a marker could potentially be used for early detection, but it could also help to track tumor recurrence following hysterectomy. This is important, as extra-vaginal recurrence of endometrial endometrioid ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Bolivar, Ana M., Luthra, Rajyalakshmi, Mehrotra, Meenakshi, Chen, Wei, Barkoh, Bedia A., Peter Hu, Zhang, Wei, Broaddus, Russell R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395490/
https://www.ncbi.nlm.nih.gov/pubmed/30315273
http://dx.doi.org/10.1038/s41379-018-0158-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6395490/
https://www.ncbi.nlm.nih.gov/pubmed/30315273
http://dx.doi.org/10.1038/s41379-018-0158-8

Ejemplares similares